Skip to main content
. 2022 Mar 3;7:16. doi: 10.1038/s41525-022-00289-x

Fig. 4. Metabotype clusters can distinguish individuals with cancer versus those with ASD/DD.

Fig. 4

a Differential abundance analysis adjusted for age and sex identified differentially underexpressed and overexpressed metabolite ratio tests in media from samples of PHTS individuals with ASD/DD relative to PHTS individuals with cancer. Correlation plot showing prominent negative correlation blocks (red rectangles). Circles shown are for results significant at P < 0.05, with increasing diameter/color corresponding with increasing correlation (circles omitted otherwise). b Using the media compartment, unsupervised hierarchical clustering shows that significant differentially abundant metabotypes distinctly separate PHTS individuals with cancer from those who have ASD/DD, with the exception of two patients. ASD autism spectrum disorder, DD developmental delay.